المؤلفون: C Chouaid, N Girard, A Kron, M Scheffler, C Knott, L Bosquet, J Trigo, S Viteri, M Sebastian, S Popat, N Rahhali, R Toueg, B Rodrigues, J Diels, CA Schioppa, J Cabrieto, J Sermon, NJ Perualila, N Erdmann, J Mielke, M Nematian-Samani, I Pfaira, C Martin-Fernandez, P Mahadevia, T Li, C Pick-Lauer, A Adamczyk, J Penton, J Wolf

المصدر: Value in Health. 25:S32

مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b96eebb8bd08ca951e7758986743303e
https://doi.org/10.1016/j.jval.2022.09.152

المؤلفون: Girard N; Institut Curie, Institut du Thorax Curie-Montsouris, 42 Bd Jourdan, Paris 75014, France. Electronic address: nicolas.girard2@curie.fr., Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, the Republic of Korea., Lee SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, the Republic of Korea., Viteri S; Instituto Oncológico Dr Rosell, Hospital Universitario Dexeus, Grupo Quirónsalud, Carrer de Sabino Arana, 5, Barcelona 08028, Spain., Schioppa CA; Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse B-2340, Belgium., Diels J; Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse B-2340, Belgium., Oguz M; Janssen-Cilag, 50-100 Holmers Farm Way, High Wycombe HP12 4EG, United Kingdom., Rodrigues BH; Janssen-Cilag, Lagoas Park, Edifício 9, Porto Salvo 2740-262, Portugal., Rahhali N; Janssen-Cilag, 1 rue Camille Desmoulins, Issy-les-Moulineaux 92130, France., Sermon J; Janssen-Cilag NV, Turnhoutseweg 30, Beerse B-2340, Belgium., Ghilotti F; Janssen-Cilag SpA, Via Michelangelo Buonarroti, 23, Cologno Monzese 20093, Italy., Li T; Janssen Research & Development, 1000 U.S. Route 202 South, Raritan, NJ 08869, United States., Thayu M; Janssen Research & Development, 1400 McKean Rd, Spring House, PA 19002, United States., Knoblauch RE; Janssen Research & Development, 1400 McKean Rd, Spring House, PA 19002, United States., Mahadevia P; Janssen Research & Development, 1000 U.S. Route 202 South, Raritan, NJ 08869, United States., Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, the Republic of Korea.

المصدر: Cancer treatment and research communications [Cancer Treat Res Commun] 2024 Jul 09; Vol. 40, pp. 100832. Date of Electronic Publication: 2024 Jul 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE

المؤلفون: Kim TM; Hemato-Oncology and Medical Oncology Center, Seoul National University Hospital, Seoul, 03080, Korea., Girard N; Medical Oncology, Institut Curie, Institut du Thorax Curie-Montsouris, Paris cedex 05, 75248, France., Leighl NB; Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada., Sabari J; Medical Oncology, New York University Langone Health, New York, NY 10016, USA., Rahhali N; Janssen Cilag, Île-de-France, 92787, France., Schioppa CA; Janssen Pharmaceutica NV, Beerse, B-2340, Belgium., Diels J; Janssen Pharmaceutica NV, Beerse, B-2340, Belgium., Sermon J; Janssen Pharmaceutica NV, Beerse, B-2340, Belgium., Chandler C; Evidence Synthesis, Modeling & Communication, Evidera, Waltham, MA 02451, USA., Kapetanakis V; Evidence Synthesis, Modeling & Communication, Evidera, London, W6 8BJ, UK., Jain R; Janssen R&D, Raritan, NJ 08869, USA., Li T; Janssen R&D, Raritan, NJ 08869, USA., Sanden SV; Janssen Pharmaceutica NV, Beerse, B-2340, Belgium.

المصدر: Future oncology (London, England) [Future Oncol] 2024 Mar; Vol. 20 (8), pp. 447-458. Date of Electronic Publication: 2023 Oct 26.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Aniline Compounds* , Antibodies, Bispecific* , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Indoles* , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Pyrimidines*, Humans ; ErbB Receptors/genetics ; Exons ; Mutation ; Platinum ; Protein Kinase Inhibitors/adverse effects

المؤلفون: Christopoulos P; Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, 69126 Heidelberg, Germany.; German Center for Lung Research (DZL), 35392 Gießen, Germany., Girard N; Institut Curie, Institut du Thorax Curie-Montsouris, 75005 Paris, France.; Paris Saclay University, University of Versailles Saint-Quentin-en-Yvelines (UVSQ), 78000 Versailles, France., Proto C; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Soares M; Instituto Português de Oncologia do Porto Francisco Gentil, 4200-072 Porto, Portugal., Lopez PG; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain., van der Wekken AJ; University of Groningen, University Medical Centre Groningen, 9713 GZ Groningen, The Netherlands., Popat S; The Royal Marsden Hospital, London SW3 6JJ, UK.; The Institute of Cancer Research, London SW7 3RP, UK., Diels J; Janssen Pharmaceutica NV, 2340 Beerse, Belgium., Schioppa CA; Janssen Pharmaceutica NV, 2340 Beerse, Belgium., Sermon J; Janssen Pharmaceutica NV, 2340 Beerse, Belgium., Rahhali N; Janssen-Cilag Ltd., 92130 Issy-les-Moulineaux, France., Pick-Lauer C; Janssen-Cilag GmbH, 41470 Neuss, Germany., Adamczyk A; Janssen-Cilag Ltd., 28042 Madrid, Spain., Penton J; Janssen-Cilag Ltd., High Wycombe HP12 4EG, UK., Wislez M; Hôpital Cochin, APHP, 75014 Paris, France.

المصدر: Cancers [Cancers (Basel)] 2023 Nov 08; Vol. 15 (22). Date of Electronic Publication: 2023 Nov 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Chouaid C; Service de Pneumologie, Pneumology, Intercommunal Hospital, 40 avenue de Verdun, 94010, Créteil, France. christos.chouaid@chicreteil.fr., Bosquet L; Health Data and Partnerships Department, Unicancer, Paris, France., Girard N; Institut Curie, Paris, France., Kron A; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.; Network Genomic Medicine, Cologne, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Scheffler M; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.; Network Genomic Medicine, Cologne, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Griesinger F; Department of Hematology and Oncology, University Department Internal Medicine-Oncology, Pius-Hospital, University Medicine Oldenburg, Oldenburg, Germany., Sebastian M; Department of Medicine, Hematology and Oncology, University of Frankfurt, Frankfurt, Germany., Trigo J; Hospital Universitario Virgen de la Victoria y Regional, IBIMA, Malaga, Spain., Viteri S; UOMI Cancer Center, Clínica Mi Tres Torres, Barcelona, Spain.; Instituto Oncológico Dr Rosell, Hospital Universitari Dexeus, Grupo QuironSalud, Barcelona, Spain., Knott C; Health Data Insight CIC, Cambridge, UK.; National Disease Registration Service, NHS Digital, Leeds, UK., Rodrigues B; Janssen Cilag, Porto Salvo, Portugal., Rahhali N; Janssen Cilag, Île-de-France, France., Cabrieto J; Janssen Pharmaceutica NV, Beerse, Belgium., Diels J; Janssen Pharmaceutica NV, Beerse, Belgium., Perualila NJ; Janssen Pharmaceutica NV, Beerse, Belgium., Schioppa CA; Janssen Pharmaceutica NV, Beerse, Belgium., Sermon J; Janssen Pharmaceutica NV, Beerse, Belgium., Toueg R; Janssen Cilag, Île-de-France, France., Erdmann N; Janssen-Cilag GmbH, Neuss, Germany., Mielke J; Janssen-Cilag GmbH, Neuss, Germany., Nematian-Samani M; Janssen-Cilag GmbH, Neuss, Germany., Martin-Fernandez C; Janssen-Cilag Ltd, High Wycombe, UK., Pfaira I; Janssen-Cilag Ltd, High Wycombe, UK., Li T; Janssen R&D, Raritan, NJ, USA., Mahadevia P; Janssen R&D, Raritan, NJ, USA., Wolf J; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.; Network Genomic Medicine, Cologne, Germany.

المصدر: Advances in therapy [Adv Ther] 2023 Mar; Vol. 40 (3), pp. 1187-1203. Date of Electronic Publication: 2023 Jan 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Antineoplastic Agents*/therapeutic use, Humans ; United States ; Mutagenesis, Insertional ; ErbB Receptors/genetics ; ErbB Receptors/therapeutic use ; Mutation ; Protein Kinase Inhibitors/therapeutic use